Jinshan Chen
11Patents
7h-index
59Co-inventors
69Inventor score
Filing activity: May 15, 1997 → Mar 6, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7271262B2 | Pyrrolopyrimidine derivatives | Human Necessities | 53 | Expired |
| US6344476B1 | Inhibition of p38 kinase activity by aryl ureas | Emerging Cross-Sectional Technologies | 35 | Expired |
| US5968795A | Biaryl acetylenes as inhibitors of matrix metalloproteases | Chemistry; Metallurgy | 17 | Expired |
| US7585869B2 | Substituted heterocylces for the treatment of abnormal cell growth | Chemistry; Metallurgy | 17 | Expired |
| US7435739B2 | Substituted pyrrolopyrimidines useful in the treatment of cancer | Human Necessities | 12 | Expired |
| US6353006B1 | Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents | Chemistry; Metallurgy | 11 | Expired |
| US8809333B2 | Imidazole, pyrazole, and triazole derivatives useful as antibacterial agents | Emerging Cross-Sectional Technologies | 7 | Active |
| US8748466B2 | Isoxazole derivatives useful as antibacterial agents | Chemistry; Metallurgy | 4 | Active |
| US7595325B2 | Substituted pyrrolo[2,3-d]pyrimidine derivatives useful in cancer treatment | Human Necessities | 2 | Active |
| US5932577A | Substituted oxobutyric acids as matrix metalloprotease inhibitors | Chemistry; Metallurgy | 0 | Expired |
| US11312713B2 | Imidazo[4,5-C]quinoline derivatives as LRRK2 inhibitors | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.